Intelligent Bio Solutions Inc.
INBS · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $1 | $0 |
| % Growth | -1.9% | 147.6% | – | – |
| Cost of Goods Sold | $2 | $2 | $1 | $0 |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 40.8% | 45.8% | 26% | – |
| R&D Expenses | $2 | $2 | $1 | $4 |
| G&A Expenses | $7 | $9 | $0 | $5 |
| SG&A Expenses | $9 | $9 | $8 | $5 |
| Sales & Mktg Exp. | $2 | $1 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $4 | -$0 |
| Operating Expenses | $12 | $12 | $13 | $8 |
| Operating Income | -$11 | -$10 | -$13 | -$8 |
| % Margin | -348.7% | -330.5% | -1,002.1% | – |
| Other Income/Exp. Net | $0 | $0 | $2 | $0 |
| Pre-Tax Income | -$11 | -$10 | -$11 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$10 | -$11 | -$8 |
| % Margin | -346.2% | -326.4% | -845.9% | – |
| EPS | -20 | -63.8 | -105.8 | -113.3 |
| % Growth | 68.7% | 39.7% | 6.6% | – |
| EPS Diluted | -20 | -63.8 | -105.8 | -113.3 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$9 | -$9 | -$9 | -$8 |
| % Margin | -309.7% | -299.1% | -753.8% | – |